Canada markets close in 12 minutes

Armata Pharmaceuticals, Inc. (ARMP)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.5900-0.0350 (-1.33%)
As of 03:21PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
30,262
33,770
35,017
20,015
14,444
-
Selling General and Administrative
7,850
11,649
7,437
8,281
7,966
-
Total Operating Expenses
32,666
40,890
36,946
23,822
21,587
-
Operating Income or Loss
-32,666
-40,890
-36,946
-23,822
-21,587
-
Interest Expense
0
2,626
0
64
628
-
Total Other Income/Expenses Net
-35,571
-25,708
-
726
6
445
Income Before Tax
-32,650
-69,045
-36,917
-23,155
-22,181
-
Income from Continuing Operations
-32,650
-69,045
-36,917
-23,155
-22,181
-
Net Income
-32,650
-69,045
-36,917
-23,155
-22,181
-
Net Income available to common shareholders
-32,650
-69,045
-36,917
-23,155
-22,181
-
Basic EPS
-1.65
-1.91
-1.08
-0.96
-1.35
-
Diluted EPS
-1.65
-1.91
-1.08
-0.96
-1.35
-
Basic Average Shares
36,066
36,076
34,294
24,104
16,415
-
Diluted Average Shares
36,066
36,076
34,294
24,104
16,415
-